Anastas Gegov

Implant Sciences Corporation (OTCMKTS:IMSC) Climbing Up

by Anastas Gegov May 2, 2016

The direction of Implant Sciences Corporation (OTCMKTS:IMSC, IMSC message board)'s stock changed in March and after a long period of sliding down the charts we finally saw the ticker gain some altitude. Meanwhile, we have seen some explosive sessions in which IMSC’s volumes were increased significantly.

 

There have been a few reasons for the good performance that we see from IMSC lately. First of all, the company isn’t doing that badly when it comes to operations. Here is a quick example of some of the numbers contained in the balance sheet of the report for the quarter that ended on December 31.

 

  • cash: $776 thousand
  • current assets: $14.5 million
  • current liabilities: $96 million
  • revenues: $10.2 million
  • net loss: $3.3 million

 

On the good note, IMSC has generates substantial revenues that have greatly increased year-over-year. On the other hand, we see that the company has a massive amount of liabilities, owing over $85 million to Montsant Partners LLC, BAM Administrative Services LLC and DMRJ Group LLC.

 

Still, IMSC managed to negotiate an extension on the maturity dates of its debt that had a maturity date of March 31, 2016. The extension, however, isn’t that big so IMSC will be in trouble by the end of the year. There are still some optimistic investors that thing the company might be sold to some of the giants in its sector, but only time can tell if that will happen.

 

Meanwhile, IMSC finished last week decently. It closed Friday’s session with a gain of 8.98%, sitting at $0.534 at the final bell. A total of 543 thousand shares switched hands and generated $289 thousand in daily dollar volume.

 

There was an optimistic press release from this morning, announcing that IMSC had received the 2016 DHS Small Business Achievement Award. This might provide the ticker with some more lift in today’s trading, but you should still be certain to do your due diligence and weigh out the risks before putting any money on the line.

Comments 1

1. Guest
May 02, 2016, 02:54PM

Quotes A press release came out by L3 that their products will be in the same booth as Implant Sciences at a big show in Australia. That is huge news and could signal a future partnership at a minimum or all out buyout. Another reason for the increased volume and share price movement lately.

Type the characters that you see in the box (5 characters).